日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Asciminib plus dasatinib and prednisone for Philadelphia chromosome-positive acute leukemia

阿西米尼联合达沙替尼和泼尼松治疗费城染色体阳性急性白血病

Luskin, Marlise R; Murakami, Mark A; Keating, Julia; Flamand, Yael; Winer, Eric S; Garcia, Jacqueline S; Stahl, Maximilian; Stone, Richard M; Wadleigh, Martha; Jaeckle, Stella L; Hagopian, Ella; Weinstock, David M; Liegel, Jessica; McMasters, Malgorzata; Wang, Eunice S; Stock, Wendy; DeAngelo, Daniel J

Combining MCL-1 inhibition and CD37-directed chimeric antigen receptor T cells as an effective strategy to target T-cell lymphoma

将MCL-1抑制剂与CD37靶向嵌合抗原受体T细胞相结合,是治疗T细胞淋巴瘤的有效策略。

Heavican-Foral, Tayla B; Korell, Felix; Scarfò, Irene; Wiggers, Caroline R M; B, Allen Thayakumar; Eisenbies, Zachary; Powers, Foster; Hegel, Justin; Liu, Jianlin; Kulp, Steffen; Silva, Harrison; Wu, Gongwei; Letai, Anthony; Stegmaier, Kimberly; Lohr, Jens G; Weinstock, David M; Maus, Marcela V; Knoechel, Birgit

Integrating Single-Cell Biophysical and Transcriptomic Features to Resolve Functional Heterogeneity in Mantle Cell Lymphoma.

整合单细胞生物物理和转录组特征以解析套细胞淋巴瘤的功能异质性

Zhang Ye, Debaize Lydie, Langenbucher Adam, Weekes Jenalyn, Vogiatzi Ioulia, Miettinen Teemu P, Zhang Mingzeng, Sumpena Emily, Liu Huiyun, Duquette Sarah M, Hackett Liam, Zhang Jeremy, Baghiyan Sona, Redd Robert A, Aryee Martin, Davids Matthew S, Kim Austin I, Ryan Christine E, Weinstock David M, Manalis Scott R, Murakami Mark A

Targeting lysine demethylase 5 (KDM5) in mantle cell lymphoma

靶向赖氨酸去甲基化酶 5 (KDM5) 治疗套细胞淋巴瘤

Xu, Danmei; Bewicke-Copley, Findlay; Close, Karina; Okosun, Jessica; Gale, Robert Peter; Apperley, Jane; Weinstock, David M; Wendel, Hans-Guido; Fitzgibbon, Jude

Acquired Multidrug Resistance in AML Is Caused by Low Apoptotic Priming in Relapsed Myeloblasts.

AML获得性多药耐药是由复发性髓母细胞凋亡启动不足引起的

Olesinski Elyse A, Bhatia Karanpreet Singh, Wang Chuqi, Pioso Marissa S, Lin Xiao Xian, Mamdouh Ahmed M, Ng Shu Xuan, Sandhu Vedant, Jasdanwala Shaista Shabbir, Yilma Binyam, Bohl Stephan, Ryan Jeremy A, Malani Disha, Luskin Marlise R, Kallioniemi Olli, Porkka Kimmo, Adamia Sophia, Chng Wee Joo, Osato Motomi, Weinstock David M, Garcia Jacqueline S, Letai Anthony, Bhatt Shruti

Geographic EBV variants confound disease-specific variant interpretation and predict variable immune therapy responses

EBV的地理变异会使疾病特异性变异的解读变得复杂,并预测免疫治疗反应的差异。

Briercheck, Edward L; Ravishankar, Shashidhar; Ahmed, Elshafa Hassan; Carías Alvarado, César Camilo; Barrios Menéndez, Juan Carlos; Silva, Oscar; Solórzano-Ortiz, Elizabeth; Siliézar Tala, Marcos Mauricio; Stevenson, Philip; Xu, Yuexin; Wohns, Anthony Wilder; Enriquez-Vera, Daniel; Barrionuevo, Carlos; Yu, Shan-Chi; Freud, Aharon G; Oakes, Christopher; Weigel, Christoph; Weinstock, David M; Klimaszewski, Haley L; Ngankeu, Apollinaire; Mutalima, Nora; Samayoa-Reyes, Gabriela; Newton, Robert; Rochford, Rosemary; Valvert, Fabiola; Natkunam, Yasodha; Shustov, Andrei; Baiocchi, Robert A; Warren, Edus H

TP63 fusions drive multicomplex enhancer rewiring, lymphomagenesis, and EZH2 dependence

TP63融合驱动多复合物增强子重编程、淋巴瘤发生和EZH2依赖性

Wu, Gongwei; Yoshida, Noriaki; Liu, Jihe; Zhang, Xiaoyang; Xiong, Yuan; Heavican-Foral, Tayla B; Mandato, Elisa; Liu, Huiyun; Nelson, Geoffrey M; Yang, Lu; Chen, Renee; Donovan, Katherine A; Jones, Marcus K; Roshal, Mikhail; Zhang, Yanming; Xu, Ran; Nirmal, Ajit J; Jain, Salvia; Leahy, Catharine; Jones, Kristen L; Stevenson, Kristen E; Galasso, Natasha; Ganesan, Nivetha; Chang, Tiffany; Wu, Wen-Chao; Louissaint, Abner; Debaize, Lydie; Yoon, Hojong; Dal Cin, Paola; Chan, Wing C; Ho Sui, Shannan J; Ng, Samuel Y; Feldman, Andrew L; Horwitz, Steven M; Adelman, Karen; Fischer, Eric S; Chen, Chun-Wei; Weinstock, David M; Brown, Myles

A phase 2 biomarker-driven study of ruxolitinib demonstrates effectiveness of JAK/STAT targeting in T-cell lymphomas

一项以生物标志物为导向的 2 期鲁索替尼研究表明,JAK/STAT 靶向治疗对 T 细胞淋巴瘤有效。

Moskowitz, Alison J; Ghione, Paola; Jacobsen, Eric; Ruan, Jia; Schatz, Jonathan H; Noor, Sarah; Myskowski, Patricia; Vardhana, Santosha; Ganesan, Nivetha; Hancock, Helen; Davey, Theresa; Perez, Leslie; Ryu, Sunyoung; Santarosa, Alayna; Dowd, Jack; Obadi, Obadi; Pomerantz, Lauren; Yi, Nancy; Sohail, Samia; Galasso, Natasha; Neuman, Rachel; Liotta, Brielle; Blouin, William; Baik, Jeeyeon; Geyer, Mark B; Noy, Ariela; Straus, David; Kumar, Priyadarshini; Dogan, Ahmet; Hollmann, Travis; Drill, Esther; Rademaker, Jurgen; Schoder, Heiko; Inghirami, Giorgio; Weinstock, David M; Horwitz, Steven M

RAS-protein activation but not mutation status is an outcome predictor and unifying therapeutic target for high-risk acute lymphoblastic leukemia

RAS蛋白激活而非突变状态是高危急性淋巴细胞白血病的预后预测因子和统一治疗靶点。

Koschut, David; Ray, Debleena; Li, Zhenhua; Giarin, Emanuela; Groet, Jürgen; Alić, Ivan; Kham, Shirley Kow-Yin; Chng, Wee Joo; Ariffin, Hany; Weinstock, David M; Yeoh, Allen Eng-Juh; Basso, Giuseppe; Nižetić, Dean

Genomic landscape of cutaneous follicular lymphomas reveals 2 subgroups with clinically predictive molecular features

皮肤滤泡性淋巴瘤的基因组图谱揭示了两个具有临床预测性分子特征的亚组。

Zhou, Xiaolong Alan; Yang, Jingyi; Ringbloom, Kimberly G; Martinez-Escala, Maria Estela; Stevenson, Kristen E; Wenzel, Alexander T; Fantini, Damiano; Martin, Haley K; Moy, Andrea P; Morgan, Elizabeth A; Harkins, Shannon; Paxton, Christian N; Hong, Bo; Andersen, Erica F; Guitart, Joan; Weinstock, David M; Cerroni, Lorenzo; Choi, Jaehyuk; Louissaint, Abner